The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence

SIMPLE SUMMARY: PSMA-PET is currently recommended to restage PCa and to guide salvage treatments. We aim to evaluate the oncologic outcomes of patients with recurrent PCa who received PSMA-PET. PSMA-PET may be a prognostic tool in BCR patients after PR. In recurrent PCa patients who never received p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchi, Lorenzo, Ceci, Francesco, Costa, Francesco, Balestrazzi, Eleonora, Droghetti, Matteo, Piazza, Pietro, Pissavini, Alessandro, Mei, Riccardo, Farolfi, Andrea, Castellucci, Paolo, Puliatti, Stefano, Larcher, Alessandro, Gandaglia, Giorgio, Robesti, Daniele, Mottrie, Alexandre, Briganti, Alberto, Morganti, Alessio Giuseppe, Fanti, Stefano, Montorsi, Francesco, Schiavina, Riccardo, Brunocilla, Eugenio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818949/
https://www.ncbi.nlm.nih.gov/pubmed/36612242
http://dx.doi.org/10.3390/cancers15010247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818949/
https://www.ncbi.nlm.nih.gov/pubmed/36612242
http://dx.doi.org/10.3390/cancers15010247

Ejemplares similares